Merck & Co., Inc.
MRK
$131.14
$0.420.32%
Weiss Ratings | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | B- | |||
Rating Factors | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Fair | |||
Growth Index | Weak | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Good | |||
Volatility Index | Good | |||
Beta / Standard Deviation | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.20 | |||
Price History | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 4.27% | |||
30-Day Total Return | 8.47% | |||
60-Day Total Return | 8.28% | |||
90-Day Total Return | 24.52% | |||
Year to Date Total Return | 15.53% | |||
1-Year Total Return | 15.66% | |||
2-Year Total Return | 57.93% | |||
3-Year Total Return | 78.92% | |||
5-Year Total Return | 86.23% | |||
52-Week High % Change | -1.79% | |||
52-Week Low % Change | 31.85% | |||
Price | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $133.10 | |||
52-Week Low Price | $99.14 | |||
52-Week Low Price (Date) | Oct 19, 2023 | |||
52-Week High Price (Date) | Mar 27, 2024 | |||
Valuation | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 318.60B | |||
Enterprise Value | 347.83B | |||
Price/Earnings (TTM) | 947.85 | |||
Earnings Per Share (TTM) | 0.13 | |||
Earnings Per Share Growth | -97.68% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 5.30 | |||
Price/Book (Q) | 8.47 | |||
Enterprise Value/Revenue (TTM) | 5.99 | |||
Price | $130.72 | |||
Enterprise Value/EBITDA (TTM) | 41.40 | |||
Enterprise Value/EBIT | 72.49 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.53B | |||
Dividend Yield | 2.39% | |||
Div. Per Share (Most Recent) | $0.77 | |||
Dividend Per Share (TTM) | $3.00 | |||
Payout Ratio (TTM) | 2,039.73% | |||
Dividend Per Share (Most Recent) | $0.77 | |||
Company Info | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 908 740 4000 | |||
Address | 126 East Lincoln Avenue Rahway, NJ 07065 | |||
Website | www.merck.com | |||
Country | United States | |||
Year Founded | 1891 | |||
Profitability | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 8.26% | |||
Profit Margin | 0.60% | |||
Management Effectiveness | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 2.88% | |||
Return on Equity | 0.90% | |||
Income Statement | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 60.11B | |||
Total Revenue (TTM) | 60.11B | |||
Revenue Per Share | $23.73 | |||
Gross Profit (TTM) | 44.20B | |||
EBITDA (TTM) | 8.70B | |||
EBIT (TTM) | 4.97B | |||
Net Income (TTM) | 365.00M | |||
Net Income Avl. to Common (TTM) | 365.00M | |||
Total Revenue Growth (Q YOY) | 5.78% | |||
Earnings Growth (Q YOY) | -140.62% | |||
EPS Diluted (TTM) | 0.13 | |||
EPS Diluted Growth (Q YOY) | -140.99% | |||
Balance Sheet | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 7.09B | |||
Cash Per Share (Q) | $2.80 | |||
Total Current Assets (Q) | 32.17B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 37.64B | |||
Current Ratio (Q) | 1.252 | |||
Book Value Per Share (Q) | $14.84 | |||
Total Assets (Q) | 106.68B | |||
Total Current Liabilities (Q) | 25.69B | |||
Total Debt (Q) | 36.27B | |||
Total Liabilities (Q) | 69.04B | |||
Total Common Equity (Q) | 37.58B | |||
Cash Flow | MRK - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -14.08B | |||
Cash from Financing (TTM) | -4.81B | |||
Net Change in Cash (TTM) | -5.86B | |||
Levered Free Cash Flow (TTM) | 2.05B | |||
Cash from Operations (TTM) | 13.01B | |||